Top Industry Leaders in the Apoptosis Assays Market
Latest Apoptosis Assays Companies Updates:
Jan 2024
Merck KGaA (Germany) Launched their Caspase-Glo® 8 and 9 Assay Kits, offering enhanced sensitivity and selectivity for detecting specific caspase activation in apoptosis pathways.Partnered with research institutions to develop new apoptosis-based biomarkers for early disease diagnosis and treatment monitoring.
Thermo Fisher Scientific (US) Received FDA approval for their CellTrace™ CFSE Cell Proliferation Kit, a fluorescence-based assay for studying cell division and apoptosis in live cells.Introduced their QuantiGene™ Multiplex Assay Kits for simultaneous detection of multiple apoptosis-related gene expressions in a single experiment.
Bio-Rad Laboratories (US) Developed their PrimePCR™ Apoptosis Pathway Kits, providing pre-validated qPCR assays for studying key genes involved in apoptosis regulation.Collaborated with pharmaceutical companies to screen potential drug candidates targeting specific apoptotic pathways in cancer cells.
Promega Corporation (US)Announced the launch of their Apo-ONE™ Homogeneous Caspase-3/7 Apoptosis Assay, offering a simple and rapid one-step method for apoptosis detection in various cell types.Expanded their offering of Annexin V Apoptosis Detection Kits with new fluorescent probes for improved sensitivity and cell viability assessment.
Cell Signaling Technology (US)Launched their PathScan® Apoptosis Multiplex ELISA Kits, enabling simultaneous quantification of multiple apoptosis-related proteins in biological samples.Developed new antibodies targeting specific caspase cleavage products for more accurate detection of apoptotic events.
List of Apoptosis Assays Key companies in the market
-
GE Healthcare
-
Merck & Co Inc.
-
Becton, Dickinson and Company
-
Bio-Rad Laboratories
-
Thermo Fisher Scientific
-
Danaher Corporation
-
Sartorius AG
-
Geno Technology
-
GeneCopoeia Inc.
-
Promega Corporation
